🇺🇸 FDA
Patent

US 8859774

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

granted A61KA61K31/4745A61K31/497

Quick answer

US patent 8859774 (Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/4745, A61K31/497, A61K31/506, A61K31/5377